The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery
Abstract
The upward extend of malaria collectively with the emergence of resistance against predictable drugs has put enormous pressure on public health systems to introduce new malaria treatments. Heterocycles play an important role in the design and discovery of new malaria active compounds. Heterocyclic compounds have attracted significant attention for malaria treatment because of simplicity of parallelization and the examining power with regard to chemical space. Introduction of a variety of heterocyclic compounds have enabled to maintain the high levels of antimalarial potency observed for other more lipophilic analogues whilst improving the solubility and the oral bioavailability in pre-clinical species. In this review, we present an overview of recent literature to provide imminent into the applications of different heterocyclic scaffolds in fighting against malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new world malaria map: Plasmodium falciparum endemicity in 2010
Gething, P. W., Patil, A. P., Smith, D. L., Guerra, C. A., Elyazar, I. R., Johnston, G. L., Tatem, A. J., & Hay, S. I. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-378 · Cited by 1,146
Yeung, B. K. S., Zou, B., Rottmann, M., Lakshminarayana, S. B., Ang, S. H., Leong, S. Y., Tan, J., Wong, J., Keller-Maerki, S., Fischli, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100410f · Cited by 432
Effectiveness of Antimalarial Drugs
Baird, J. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043207 · Cited by 375
Shetty, P. (2012) · Nature · doi:10.1038/484s14a · Cited by 293
Kant, R., Kumar, D., Agarwal, D., Gupta, R. D., Tilak, R., Awasthi, S. K., & Agarwal, A. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.041 · Cited by 207
Guantai, E. M., Ncokazi, K., Egan, T. J., Gut, J., Rosenthal, P. J., Smith, P. J., & Chibale, K. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.10.009 · Cited by 203
Raj, R., Singh, P., Singh, P., Gut, J., Rosenthal, P. J., & Kumar, V. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.032 · Cited by 149
Braulio Insuasty, O., Montoya, A. L., Becerra, D., Jairo Quiroga, P., Abonía, R., Robledo, S. M., Vélez, I. D., Upegui, Y., Nogueras, M., & Cobo, J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.049 · Cited by 134
Camacho, J., Barazarte, A. R., Gamboa, N., Rodrigues, J. R., Rojas, R., Vaisberg, A., Gilman, R., & Charris, J. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.050 · Cited by 112
Satasia, S. P., Kalaria, P. N., & Raval, D. K. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42132e · Cited by 86
Self-citation
Cited by
A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications
Kerru, N., Gummidi, L., Maddila, S., Gangu, K. K., & Jonnalagadda, S. B. (2020) · Molecules · doi:10.3390/molecules25081909 · Cited by 1,716
Xu, Z., Zhao, S.-J., & Liu, Y. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111700 · Cited by 520
Triazole derivatives and their antiplasmodial and antimalarial activities
Chu, X.-M., Wang, C., Wang, W.-L., Liang, L.-L., Liu, W., Gong, K.-K., & Sun, K.-L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.047 · Cited by 287
Metadata
- Authors
- Kalaria, P. N., Karad, S. C., & Raval, D. K.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 158
- Pages
- 917-936
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2885251794
- Cited by
- 436
- References
- 41
- FWCI
- 25.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.